In a rat model of adenine-induced chronic kidney disease (CKD), adropin was found to reduce urine protein levels and 24-hour urine volume and downregulate inflammatory markers such as TIMP-1, IL-33, and MMP-2, suggesting a protective effect against renal damage and inflammation [121]. Here, IL33 is linked to chronic kidney disease.